IM Cannabis (IMCC) vs Sonoma Pharmaceuticals (SNOA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sonoma Pharmaceuticals is the larger company by market cap ($5.6 million vs $2.7 million), about 2.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMCC | SNOA |
|---|---|---|
| Share price | $1.61 | $1.18 |
| Market cap | $2.65M | $5.63M |
| 1-day change | -6.36% | +1.29% |
| EPS (TTM) | $-71.41 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $77.10 | $4.30 |
| 52-week low | $1.55 | $0.85 |
| Distance from 52-week high | -97.91% | -72.67% |
| Average volume | 2.75M | 107.65K |
| Shares outstanding | 1.65M | 4.79M |
| Employees | 44 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Sonoma Pharmaceuticals is about 2.1 times larger than IM Cannabis by market value ($5.63M vs $2.65M).
About IM Cannabis
IMCC stock →IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany.
Health Care · Medicinal Chemicals and Botanical Products · 44 employees
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Health Care · Medical/Dental Instruments · 10 employees
IMCC vs SNOA FAQ
Which is bigger, IM Cannabis or Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals (SNOA) is larger, with a market capitalization of $5.63M compared with $2.65M for IM Cannabis (IMCC).
Are IM Cannabis and Sonoma Pharmaceuticals in the same industry?
Both are in the Health Care sector, but in different industries: Medicinal Chemicals and Botanical Products for IM Cannabis and Medical/Dental Instruments for Sonoma Pharmaceuticals.